Cancer Biomarker Market Analysis By Type (Breast, Prostate, Colorectal, Cervical, Liver, Lung Cancer), By Biomolecule (Genetic, Epigenetic, Metabolic, Proteomic), By Application, And Segment Forecasts, 2014 - 2025

  • ID: 4312565
  • Report
  • 85 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Affymetrix Inc
  • Agilent Technologies
  • F. Hoffmann-La Roche Ltd
  • Hologic, Inc.
  • Illumina, Inc
  • MORE
The global cancer biomarkers market is expected to reach a value of USD 33.7 billion by 2025. Growing initiatives for development of drugs targeting novel cancer biomarkers coupled with the introduction of technologically advanced companion diagnostic kits is estimated to provide the market with high growth potential. Increasing awareness about personalized medicines amongst patients is further anticipated to boost adoption of cancer biomarkers.

In addition, presence of favorable government initiatives for the development of novel cancer diagnostic techniques is a key factor for market growth. For instance, the National Cancer Institute (NCI) provides funding to more than 8 research areas pertaining to cancer biomarker development. Cancer Research UK, Lung Cancer Research Foundation, and National Institutes of Health are some of the organizations providing funding for biomarker research.

People with high alcohol consumption, tobacco usage, unhealthy food habits, and sedentary lifestyle are reported to be 80% more at risk of developing cancer as compared to other individuals. Infections such as Human papillomavirus (HPV), Epstein-Barr virus, Hepatitis B virus, and Helicobacter pylori are also been studied to be related in cancer development.

Further Key findings from the study suggest:
  • Breast cancer was the largest segment by revenue share in 2016 owing to high prevalence of this type of cancer
  • Lung cancer is estimated to be the fastest-growing type due to increasing research activities toward development of novel lung cancer biomarkers
  • Genetic biomarkers, being the highest used and easily detectable held the majority share of cancer biomarker market by biomolecule in 2016
  • However, epigenetic biomarkers are anticipated to witness lucrative growth due to increasing focus on finding the role of epigenetic modifications in cancer development
  • Cancer biomarkers are majorly used for diagnostic purpose owing to their high specificity
  • The personalized medicine segment is estimated to witness fastest CAGR of 15.0% over the forecast period
  • North America dominated in terms of revenue share in 2016 due to established R&D infrastructure and high acceptance of biomarker-based cancer testing in this region
  • Asia Pacific is anticipated to grow at a substantial growth rate till 2025 with CAGR of over 16.7%
  • Some of the major companies in the cancer biomarkers market are Abbott Laboratories; F.Hoffmann-La Roche Ltd.; QIAGEN; Thermo Fisher Scientific Inc.; Affymetrix Inc.; Illumina, Inc.; Agilent Technologies; Merck & Co. Inc.; Hologic, Inc.; Sino Biological Inc.; and Becton, Dickinson and Company
PLEASE NOTE: This report will be completed after order and will take approximately 1-2 business days after the confirmation of payment.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Affymetrix Inc
  • Agilent Technologies
  • F. Hoffmann-La Roche Ltd
  • Hologic, Inc.
  • Illumina, Inc
  • MORE
1. Methodology and Scope
1.1. Information Procurement
1.1.1. Purchased database:
1.1.2. Internal database
1.2. Research Methodology
1.3. Geographic Scope & Assumptions
1.4. Region-wise Market Calculation
1.4.1. Region-wise market: Base estimates
1.4.2. Global market: CAGR calculation
1.5. Region-based Segment Share Calculation
1.6. List of Secondary Sources
2. Executive Summary
2.1. Market Snapshot
3. Cancer Biomarkers Industry Outlook
3.1. Market Segmentation & Scope
3.1.1. Market driver analysis
3.1.1.1 Growing geriatric population base
3.1.1.2 Growing prevalence of cancer
3.1.1.3 Increasing government funding for cancer research
3.1.1.4 Technological advancements
3.1.2. Market restraint analysis
3.1.2.1 Large capital investments and production cost
3.2. Penetration & Growth Prospect Mapping
3.3. Cancer biomarkers - SWOT Analysis, By Factor (political & legal, economic and technological)
3.4. Industry Analysis - Porter’s
4. Cancer Biomarkers Market: Type Outlook
4.1. Cancer biomarkers market share by type, movement analysis
4.2. Breast cancer
4.2.1. Breast cancer Market estimates and forecast, 2014 - 2025 (USD Billion)
4.4. Prostate Cancer
4.4.1. Prostate cancer market estimates and forecast, 2014 - 2025 (USD Billion)
4.5. Colorectal Cancer
4.5.1. Colorectal cancer market estimates and forecast, 2014 - 2025 (USD Billion)
4.6. Cervical Cancer
4.6.1. Cervical cancer market estimates and forecast, 2014 - 2025 (USD Billion)
4.7. Liver Cancer
4.7.1. Liver cancer market estimates and forecast, 2014 - 2025 (USD Billion)
4.8. Lung Cancer
4.8.1. Lung cancer market estimates and forecast, 2014 - 2025 (USD Billion)
4.9. Others
4.9.1. Others market estimates and forecast, 2014 - 2025 (USD Billion)
5. Cancer biomarkers Market: Biomolecule Estimates & Trend Analysis
5.1. Cancer Biomarkers Market: Biomolecule Movement Analysis
5.2. Genetic Biomarkers
5.2.1. Genetic biomarkers market estimates and forecast, 2014 - 2025 (USD Billion)
5.3. Epigenetic Biomarkers
5.3.1. Epigenetic biomarkers market estimates and forecast, 2014 - 2025 (USD Billion)
5.4. Metabolic Biomarkers
5.4.1. Metabolic biomarkers market estimates and forecast, 2014 - 2025 (USD Billion)
5.5. Proteomic Biomarkers
5.5.1. Proteomic biomarkers market estimates and forecast, 2014 - 2025 (USD Billion)
5.6. Others
5.6.1. Others market estimates and forecast, 2014 - 2025 (USD Billion)
6. Cancer biomarkers Market: Application Estimates & Trend Analysis
6.1. Cancer Biomarkers Market: Application Movement Analysis
6.2. Drug Discovery
6.2.1. Drug discovery market estimates and forecast, 2014 - 2025 (USD Billion)
6.3. Diagnostics
6.3.1. Diagnostics market estimates and forecast, 2014 - 2025 (USD Billion)
6.4. Personalized Medicine
6.4.1. Personalized medicine market estimates and forecast, 2014 - 2025 (USD Billion)
6.5. Others
6.5.1. Others market estimates and forecast, 2014 - 2025 (USD Billion)
7. Cancer Biomarkers Market: Regional Outlook
7.1. Cancer biomarkers market share by region, 2015 & 2025 (USD Billion)
7.2. North America
7.2.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.2.1.1. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.2.1.2. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.2.1.3. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.2.2. U.S.
7.2.2.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.2.2.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.2.2.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.2.2.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.2.3. Canada
7.2.3.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.2.3.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.2.3.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.2.3.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.3. Europe
7.3.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.3.1.1. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.3.1.2. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.3.1.3. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.3.2. Germany
7.3.2.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.3.2.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.3.2.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.3.2.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.3.3. UK
7.3.3.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.3.3.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.3.3.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.3.3.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.4. Asia Pacific
7.4.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.4.1.1. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.4.1.2. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.4.1.3. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.4.2. China
7.4.2.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.4.2.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.4.2.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.4.2.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.4.3. India
7.4.3.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.4.3.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.4.3.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.4.3.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.4.4. Japan
7.4.4.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.4.4.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.4.4.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.4.4.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.5. Latin America
7.5.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.5.1.1. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.5.1.2. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.5.1.3. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.5.2. Brazil
7.5.2.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.5.2.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.5.2.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.5.2.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.5.3. Mexico
7.5.3.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.5.3.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.5.3.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.5.3.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.6. Middle East & Africa
7.6.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.6.1.1. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.6.1.2. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.6.1.3. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.6.2. South Africa
7.6.2.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.6.2.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.6.2.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.6.2.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
8. Company Profiles
8.1. Strategy Framework
8.2. Market Participation Categorization
8.3. Company Profiles
8.3.1. Abbott Laboratories
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Product benchmarking
8.3.1.4. Strategic initiatives
8.3.2. 9F. Hoffmann-La Roche Ltd
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Product benchmarking
8.3.2.4. Strategic initiatives
8.3.3. Qiagen N.V
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Product benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Affymetrix Inc
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Illumina, Inc
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Agilent Technologies
8.3.6.1. Company overview
8.3.6.2. Financial overview
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Merck & Co. Inc
8.3.7.1. Company overview
8.3.7.2. Financial overview
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Hologic, Inc.
8.3.8.1. Company overview
8.3.8.2. Financial overview
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Sino Biological Inc.
8.3.9.1. Company overview
8.3.9.2. Financial overview
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Thermo Fisher Scientific Inc.
8.3.10.1. Company overview
8.3.10.2. Financial overview
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Becton, Dickinson and Company
8.3.11.1. Company overview
8.3.11.2. Financial overview
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives

List of Tables

Table 1 Country share estimation
Table 2 North America cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 3 North America cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
Table 4 North America cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 5 U.S. cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 6 U.S. cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
Table 7 U.S. cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 8 Canada cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 9 Canada cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
Table 10 Canada cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 11 Europe cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 12 Europe cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
Table 13 Europe cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 14 UK cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 15 UK cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
Table 16 UK cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 17 Germany cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 18 Germany cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
Table 19 Germany cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 20 Asia Pacific cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 21 Asia Pacific cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
Table 22 Asia Pacific cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 23 Japan cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 24 Japan cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
Table 25 Japan cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 26 China cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 27 China cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
Table 28 China cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 29 India cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 30 India cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
Table 31 India cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 32 Latin America cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 33 Latin America cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
Table 34 Latin America cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 35 Brazil cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 36 Brazil cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
Table 37 Brazil cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 38 Mexico cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 39 Mexico cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
Table 40 Mexico cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 41 MEA cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 42 MEA cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
Table 43 MEA cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 44 South Africa cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 45 South Africa cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
Table 46 South Africa cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)

List of Figures

Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Value chain based sizing & forecasting
Figure 4 QFD modeling for market share assessment
Figure 5 Market summary
Figure 6 Market trends &outlook
Figure 7 Market segmentation & scope
Figure 8 Market driver relevance analysis (Current & future impact)
Figure 9 Global percentage of population, by age group, 2050 and 2000
Figure 10 Market restraint relevance analysis (Current & future impact)
Figure 11 Penetration & growth prospect mapping
Figure 12 SWOT Analysis, By Factor (political & legal, economic and technological)
Figure 13 Porter’s Five Forces Analysis
Figure 14 Cancer biomarkers market type outlook key takeaways
Figure 15 Cancer biomarkers market: Type movement analysis
Figure 16 Global breast cancer market, 2014 - 2025 (USD Billion)
Figure 17 Global prostate cancer market, 2014 - 2025 (USD Billion)
Figure 18 Global colorectal cancer market, 2014 - 2025 (USD Billion)
Figure 19 Global cervical cancer market, 2014 - 2025 (USD Billion)
Figure 20 Global liver cancer market, 2014 - 2025 (USD Billion)
Figure 21 Global lung cancer market, 2014 - 2025 (USD Billion)
Figure 22 Global other cancer market, 2014 - 2025 (USD Billion)
Figure 23 Cancer biomarkers market biomolecule outlook key takeaways
Figure 24 Cancer biomarkers market: Biomolecule movement analysis
Figure 25 Global genetic biomarkers market, 2014 - 2025 (USD Billion)
Figure 26 Global epigenetic biomarkers market, 2014 - 2025 (USD Billion)
Figure 27 Global metabolic biomarkers market, 2014 - 2025 (USD Billion)
Figure 28 Global proteomic biomarkers market, 2014 - 2025 (USD Billion)
Figure 29 Global other biomarkers market, 2014 - 2025 (USD Billion)
Figure 30 Cancer biomarkers market application outlook key takeaways
Figure 31 Cancer biomarkers market: Application movement analysis
Figure 32 Drug discovery market, 2014 - 2025 (USD Billion)
Figure 33 Diagnostics market, 2014 - 2025 (USD Billion)
Figure 34 Personalized medicine market, 2014 - 2025 (USD Billion)
Figure 35 Others market, 2014 - 2025 (USD Billion)
Figure 36 Regional market place: Key takeaways
Figure 37 Regional outlook, 2015 & 2025
Figure 38 North America Cancer biomarkers market, 2014 - 2025 (USD Billion)
Figure 39 U.S. cancer biomarkers market, 2014 - 2025 (USD Billion)
Figure 40 Canada cancer biomarkers market, 2014 - 2025 (USD Billion)
Figure 41 Europe cancer biomarkers market, 2014 - 2025 (USD Billion)
Figure 42 UK cancer biomarkers market, 2014 - 2025 (USD Billion)
Figure 43 Germany cancer biomarkers market, 2014 - 2025 (USD Billion)
Figure 44 Asia Pacific cancer biomarkers market, 2014 - 2025 (USD Billion)
Figure 45 Japan cancer biomarkers market, 2014 - 2025 (USD Billion)
Figure 46 China cancer biomarkers market, 2014 - 2025 (USD Billion)
Figure 47 India cancer biomarkers market, 2014 - 2025 (USD Billion)
Figure 48 Latin America cancer biomarkers market, 2014 - 2025 (USD Billion)
Figure 49 Brazil cancer biomarkers market, 2014 - 2025 (USD Billion)
Figure 50 Mexico cancer biomarkers market, 2014 - 2025 (USD Billion)
Figure 51 MEA cancer biomarkers market, 2014 - 2025 (USD Billion)
Figure 52 South Africa cancer biomarkers market, 2014 - 2025 (USD Billion)
Figure 53 Strategy framework
Figure 54 Participant categorization
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Qiagen N.V
  • Affymetrix Inc
  • Illumina, Inc
  • Agilent Technologies
  • Merck & Co. Inc
  • Hologic, Inc.
  • Sino Biological Inc.
  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll